Table 4.
Variables | Total (N=700) | |||
---|---|---|---|---|
| ||||
Participants (n) | Seropositive (n) | Proportion of seropositive (%) (95% CI) | Adjusted prevalence (%) 95% CI | |
Male | 362 | 192 | 53.0 (47.7-58.3) | 56.1 (50.8-61.3) |
Female | 338 | 198 | 58.6 (53.1-63.8) | 62.1 (56.7-67.3) |
1-4 years | 33 | 14 | 42.4 (25.5-60.8) | 45.0 (28.1-63.6) |
5-9 years | 153 | 67 | 43.8 (35.8-52.0) | 46.4 (38.3-54.6) |
10-17 years | 512 | 309 | 60.3 (55.9-64.6) | 63.9 (59.5-68.0) |
Symptomatic | 131 | 90 | 68.7 (60.0-76.5) | 72.8 (64.0-79.9) |
Asymptomatic | 569 | 300 | 52.7 (48.5-56.9) | 55.9 (51.7-60.0) |
Total | 700 | 390 | 55.7 (51.9-59.4) | 59.0 (55.2-62.7) |
CI=confidence interval